Samsara BioCapital, LLC - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 48 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$2,464,000
+22.9%
5,938,2150.0%1.42%
+47.6%
Q4 2019$2,005,000
-22.9%
5,938,215
+64.5%
0.96%
-45.7%
Q3 2019$2,599,000
+69.4%
3,610,913
+71.1%
1.77%
+74.6%
Q2 2019$1,534,000
-66.3%
2,110,913
-43.7%
1.01%
-71.7%
Q1 2019$4,556,0003,750,0003.58%
Other shareholders

There were no reported owners of SUNESIS PHARMACEUTICALS INC in Q1 2020.

NameSharesValueWeighting ↓
View complete list of SUNESIS PHARMACEUTICALS INC shareholders